Ovid Therapeutics, Inc. (OVID)
2.795
-0.08
(-2.61%)
USD |
NASDAQ |
May 13, 16:00
2.77
-0.02
(-0.89%)
After-Hours: 20:00
Ovid Therapeutics Cash from Investing (Quarterly) : 5.95M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | -93.74M |
| CytomX Therapeutics, Inc. | -192.78M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| Amgen, Inc. | -716.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.90M |
| Cash from Financing (Quarterly) | 88.98M |
| Free Cash Flow | -41.95M |
| Free Cash Flow Per Share (Quarterly) | -0.1021 |
| Free Cash Flow to Equity (Quarterly) | -13.55M |
| Free Cash Flow to Firm (Quarterly) | -13.90M |
| Free Cash Flow Yield | -16.67% |